Cite

    Llorens, F., Kruse, N., Schmitz, M., Gotzmann, N., Golanska, E., Thüne, K., Zejneli, O., Kanata, E., Knipper, T., Cramm, M., Lange, P., Zafar, S., Sikorska, B., Liberski, P. P., Mitrova, E., Varges, D., Schmidt, C., Sklaviadis, T., Mollenhauer, B., & Zerr, I. (2017). evaluation of α‐synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimer's & dementia, 13(6), 710–719. http://access.bl.uk/ark:/81055/vdc_100102728761.0x000017